Casma Therapeutics Inks $46M Series C Funding Posted by dumbcapital | Nov 15, 2022 | Raises and Exits, Uncategorized | 0 | CAMBRIDGE, MA, Casma Therapeutics, a biotechnology company engaging the autophagy system to provide innovative new medicines, today announced the closing of a Series C financing round of $46 million.